Vir Biotechnology (VIR) Amortizatization of Intangibles (2018 - 2026)
Vir Biotechnology's (VIR) quarterly Amortizatization of Intangibles came in at -$394000.0 in Q1 2026, up 90.36% year-on-year from -$206971.5 in Q1 2025, and up 74.56% quarter-over-quarter from -$1.5 million in Q4 2025.
Vir Biotechnology (VIR) Amortizatization of Intangibles (2018 - 2026) Analysis & Trends
Vir Biotechnology has disclosed Amortizatization of Intangibles across 9 years of filings, most recently posting -$394000.0 for Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at -$394000.0, up 90.36% year-over-year; the trailing twelve-month figure through Mar 2026 was -$5.8 million (up 37.51% YoY), and the FY2025 annual result was -$9.5 million, down 75.54% from the prior year.
- Amortizatization of Intangibles came in at -$394000.0 for Q1 2026 at Vir Biotechnology, up from -$1.5 million in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $9.4 million in Q1 2023 to a low of -$4.1 million in Q1 2025.
- The 5-year median for Amortizatization of Intangibles is -$1.3 million (2025), against an average of $140235.3.
- Across the five-year window, Amortizatization of Intangibles jumped 6941.35% in 2023 and tumbled 1618.07% in 2025, its largest moves.
- Vir Biotechnology's Amortizatization of Intangibles stood at $8.5 million in 2022, then slumped by 115.81% to -$1.4 million in 2023, then tumbled by 60.47% to -$2.2 million in 2024, then increased by 28.55% to -$1.5 million in 2025, then soared by 74.56% to -$394000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at -$394000.0 (Q1 2026), -$1.5 million (Q4 2025), and -$1.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Vir Biotechnology | 1.35 Bn | 1.35 Bn | - | -394,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -394,000.00 |
| Mar 31, 2026 | -394,000.00 |
| Dec 31, 2025 | -1.55 Mn |
| Dec 31, 2025 | -1.55 Mn |
| Sep 30, 2025 | -1.32 Mn |
| Sep 30, 2025 | -1.32 Mn |
| Jun 30, 2025 | -2.52 Mn |
| Jun 30, 2025 | -2.52 Mn |
| Mar 31, 2025 | -4.09 Mn |
| Mar 31, 2025 | -4.09 Mn |
| Dec 31, 2024 | -2.17 Mn |
| Dec 31, 2024 | -2.17 Mn |
| Sep 30, 2024 | -354,000.00 |
| Sep 30, 2024 | -354,000.00 |
| Jun 30, 2024 | -2.64 Mn |
| Jun 30, 2024 | -2.64 Mn |
| Mar 31, 2024 | -238,000.00 |
| Mar 31, 2024 | -238,000.00 |
| Dec 31, 2023 | -1.35 Mn |
| Dec 31, 2023 | -1.35 Mn |